Sai Parenteral's Ltd. Share Price

Overview

Sai Parenteral's Ltd. share price is currently ₹523.95, down by - ₹0.40 (0.08%) from its previous closing price of ₹524.35. The share price has declined -5.43% over the past month and gained 0.31% over the past year. The stock's 52-week low and high are ₹393.98 and ₹697.77, respectively. Sai Parenteral's Ltd. has a market capitalisation of ₹ 2,390.00 Cr. The share price was last updated on 25 Aug 2026, 03:55 PM IST.

Sai Parenteral's Ltd.

SAIPARENT

₹0.00

- ₹0.40

0.08%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:55:20 pm IST

Market Data

Open Price

₹522.34

Prev. Close

₹524.35

₹514.31

Day Low

₹528.04

Day High

₹393.98

52 Week Low

₹697.77

52 Week High

HealthcarePharmaceuticals & Drugs

Category Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

140.09

Sector PE

42.03

PB Ratio

4.72

Sector PB

5.83

EPS

3.74

Dividend Yield

0.00

Today's Volume

82.088 K

5 Day Avg. Volume

70.103 K

PEG Ratio

-4.67

Market Cap.

₹ 2,390.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Bandhan Healthcare Fund - Regular Plan - Growth	-	56.65 k (100%)
Bandhan Midcap Fund - Regular Plan - Growth	-	22.77 k (100%)
Bandhan Large & Mid Cap Fund - Regular Plan - Growth	-	10.86 k (100%)
Quant Momentum Fund - Regular Plan - Growth	2.16 Lac	- (100%)

About Sai Parenteral's Ltd. 👋

Sai Parenteral's Ltd is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. It is in the business of branded generic formulations and contract development and manufacturing organizational products and services for the domestic and international markets. Its portfolio includes formulation products across various therapeutic areas like cardiovascular, neruopsychiatry, anti-diabetic, respiratory health, antibiotics, vitamins, minerals and supplements analgesics, and dermatology with offerings across dosage forms such as injectables, tablets, capsules, liquid orals and ointments. In the injectables segment, the Company has capabilities in sterile manufacturing for critical care and antibiotics, which are delivered through dry powder injections, pre-filled syringes, ampules, and vials. It manufactures and sells branded generic formulations to a diverse customer base, including central and state government agencies.